Navigation Links
Pfizer’s Eraxis Approved By The FD

Pfizer Inc announced the approval of a new antifungal drug, for the treatment of bloodstream infection by the FDA. The new drug called Eraxis, // is indicated in the treatment of candidemia, a hospital acquired fatal blood infection.

The improved performance of Eraxis compared to Diflucan, a currently employed anti-fungal treatment is said to have supported the approval. The drug can also be used in the treatment of infections caused by Candida (a fungus), intra-abdominal abscesses, fungal infection of the esophagus and peritonitis.

The acquisition of Vicuron Pharmaceuticals Inc. by Pfizer in September is said to have set stage for acquiring Eraxis. The company’s share value in the afternoon fell down to 18% ($25.65) on the New York Stock Exchange.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Pfizer’s Anti-smoking Dru
2. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
3. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
4. New FDA Approved Drug To Treat Migraine
5. New FDA Approved Drug NATRECOR For Heart Failure Patients
6. New Oral Rinse For Gingivitis Approved By FDA
7. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
8. AIDS Generic Drugs Approved by FDA for Sale in US
9. FDA Approved Nerve-Stimulation Therapy Now Available In New York
10. Revlimid Approved For Treatment Of Myelodysplastic Syndrome (MDS) by FDA
11. Inhalers for Kids Was Approved By the FDA
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True Influence ... of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention Center ... — representing such thought-leading companies as JP Morgan Chase, GE Digital, and ...
(Date:9/20/2017)... ... September 20, 2017 , ... Each year Athletic ... National Athletic Trainers’ Association Annual Clinical Symposium and Expo. New research is revealed, ... when Athletic Trainers are acknowledged by their peers with accolades and highly prestigious ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare and Medicaid Services (CMS) ... transition to using only Worksheet S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated Care ... 60-minute complimentary webinars on October 17, 2017 at 2 P.M. EST and uncover ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Trials I Face ... tribulations as he emotionally pens his aspirations and goals to better one’s life through ... author, Jimmy Green, while searching in all the wrong places, found a love for ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... at a gathering of executive marketers this week about the value of senior ... , "Everything that has happened in business has brought us to the present ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology: